Glycosaminoglycans as Novel Targets for in vivo Contrast-Enhanced Magnetic Resonance Imaging of Atherosclerosis
Open Access
- 20 April 2020
- journal article
- Published by Heighten Science Publications Corporation in Journal of Cardiology and Cardiovascular Medicine
- Vol. 5 (1), 080-088
- https://doi.org/10.29328/journal.jccm.1001091
Abstract
No abstract availableThis publication has 98 references indexed in Scilit:
- Monitoring of arterial wall remodelling in atherosclerotic rabbits with a magnetic resonance imaging contrast agent binding to matrix metalloproteinasesEuropean Heart Journal, 2010
- Extracellular Matrix Molecules: Potential Targets in PharmacotherapyPharmacological Reviews, 2009
- A Peptide Targeted Contrast Agent Specific to Fibrin-Fibronectin Complexes for Cancer Molecular Imaging with MRIBioconjugate Chemistry, 2008
- The endothelial glycocalyx: composition, functions, and visualizationPflügers Archiv - European Journal of Physiology, 2007
- Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRIProceedings of the National Academy of Sciences of the United States of America, 2007
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseThe New England Journal of Medicine, 2005
- Inflammation in atherosclerosisNature, 2002
- Elastin–elastase–atherosclerosis revisitedAtherosclerosis, 1998
- The extracellular matrix and atherosclerosisCurrent Opinion in Lipidology, 1995
- Proteoglycans and Potential Mechanisms Related to AtherosclerosisaAnnals of the New York Academy of Sciences, 1985